MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) Revenue 2016–2024
MATINAS BIOPHARMA HOLDINGS, INC. (MTNB) annual revenue history from SEC filings — each fiscal year as reported, with year-over-year change.
$1.1MFY2024 · since FY2016: $194,494 → $1.1M
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | $1.1M | -65.6% |
| FY2023 | $3.2M | +9560.6% |
| FY2022 | $33,000 | -79.2% |
| FY2021 | $158,333 | +76.3% |
| FY2020 | $89,812 | -25.0% |
| FY2019 | $119,750 | -20.0% |
| FY2018 | $149,687 | — |
| FY2017 | $0 | -100.0% |
| FY2016 | $194,494 | — |
Source: SEC XBRL filings · For reference only · Not investment advice